Improving management of type 2 diabetes mellitus: 4. Meglitinides.
Quillen
D M
DM
Department of Community Health and Family Practice, University of Florida College of Medicine, Gainesville, USA.
Kuritzky
L
L
Samraj
G P
GP
D002219:Carbamates / Q000009:adverse effects / Q000627:therapeutic use*; D000075202:Contraindications; D003924:Diabetes Mellitus, Type 2 / Q000188:drug therapy*; D006801:Humans; D007004:Hypoglycemic Agents / Q000009:adverse effects / Q000627:therapeutic use*; D010880:Piperidines / Q000009:adverse effects / Q000627:therapeutic use*
D002219:Carbamates; D007004:Hypoglycemic Agents; D010880:Piperidines; C072379:repaglinide